Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells

Cellular Immunology

Volumn 278, Issue 1-2, 2012, Pages 35-44

  Liu, Shuyun ^a   Yuan, Mei ^a   Hou, Kedong ^a   Zhang, Li ^a   Zheng, Xifu ^a   Zhao, Bin ^a   Sui, Xiang ^a   Xu, Wenjing ^a   Lu, Shibi ^a   Guo, Quanyi ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Chondrogenic differenciation; Immune character; Transplantation tolerance; WJMSCs

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; B7 ANTIGEN; BETA1 INTEGRIN; CD40 ANTIGEN; CD44V ANTIGEN; CD71 ANTIGEN; CD86 ANTIGEN; ENDOGLIN; HLA G ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN E2; SCATTER FACTOR; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ARTICLE; CARTILAGE CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD; WHARTON JELLY;

ANIMALS; ANTIGENS, CD; CARTILAGE; CELL DIFFERENTIATION; DINOPROSTONE; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HLA-G ANTIGENS; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-10; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RABBITS; RATS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTORS; TRANSPLANTATION, HETEROLOGOUS; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WHARTON JELLY;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84868287880     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.06.010     Document Type: Article

References (53)

1. Caplan A.I. Why are MSCs therapeutic? New data: new insight. J. Pathol. 2008, 217:318-324.
2. Sethe S., Scutt A., Stolzing A. Aging of mesenchymal stem cells. Ageing Res. Rev. 2005, 5:91-116.
3. K Gala, A Burdzinska, M Idziak, J Makula, L Paczek Characterization of bone marrow derived rat mesenchymal stem cells depending on donor age. Cell Biol. Int. 2011, 35(10):1055-1062.
4. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
5. Chen M.Y., Lie P.C., Li Z.L., et al. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrowderived mesenchymal stem cells. Exp. Hematol. 2009, 37:629-640.
6. Fong C.Y., Chak L.L., Biswas A., et al. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. 2011, 7(1):1-16.
7. Troyer D.L., Weiss M.L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008, 26(3):591-599.
8. Fibbe W.E., Nauta A.J., Roelofs H. Modulation of Immune Responses by Mesenchymal Stem Cells. Ann. N.Y. Acad. Sci 2007, 1106:272-278.
9. Patel Shyam.A., Sherman Lauren., Munoz Jessian., Rameshwar Pranela. Immunological properties of mesenchymal stem cells and clinical implications. Arch. Immunol. Ther. Exp. 2008, 56:1-8.
10. Ge W., Jiang J., Baroja M.L., Arp J., Zassoko R., Liu W., Bartholomew A., Garcia B., Wang H. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am. J. Transplant. 2009, 9:1760-1772.
11. Popp F.C., Eggenhofer E., Renner P., Slowik P., Lang S.A., Kaspar H., Geissler E.K., Piso P., Schlitt H.J., Dahlke M.H. Mesenchymal stem cells can induce longterm acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl. Immunol. 2008, 20:55-60.
12. Niemeyera P., Szalayb K., Luginbühlc R., Südkampa N.P., Kasten P. Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. Acta Biomater. 2010, 6(3):900-908.
13. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002, 30:42-48.
14. Mielcarek Marco, Storb Rainer, Georges George E., Golubev Ludmila, Nikitine Alla, Hwang Billanna, Nash Richard A., Torok-Storb Beverly Mesenchymal Stromal Cells Fail to Prevent Acute Graft-versus-Host Disease and Graft Rejection after Dog Leukocyte Antigen-Haploidentical. Bone Marrow Transplantation. Biol. Blood Marrow Transplant. 2011, 17:214-225.
15. A.J. Nauta, G. Westerhuis, A.B. Kruisselbrink, E.G. Lurvink, R. Willemze, W.E. Fibbe, Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting, Blood 15,108 (6) (2006) 2114-2120.
16. C.R. Mills, Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD, Trials 2009.
17. Macmillan M.L., Blazar B.R., DeFor T.E., et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant. 2009, 43(6):447-454.
18. Hass Ralf, Kasper Cornelia, Böhm Stefanie, Jacobs Roland. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 2011, 9:12.
19. Francese Roberto, Fiorina Paolo Immunological and regenerative properties of cord blood stem cells. Clin. Immunol. 2010, 136(3):309-322.
20. Wang Meng, Yang Yuan, Yang Dongming, Luo Fei, Liang Wenjie, Guo Shuquan, Jianzhong Xu The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009, 126(2):220-232.
21. Carraro G., Perin L., Sedrakyan S., Giuliani S., Tiozzo C., Lee J., Turcatel G., De Langhe S.P., Driscoll B., Bellusci S., Minoo P., Atala A., De Filippo R.E., Warburton D. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 2008, 26(11):2902-2911.
22. C. Ventura, et al., Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts, J. Biol. Chem. 282 (14) (2007) 243-252.
23. Weiss M.L., Anderson C., Medicetty S., Seshareddy K.B., Weiss R.J., Werff I.V., Troyer D., Mcintos K.R. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26:2865-2874.
24. Deuse T., Stubbendorff M., Tang-Quan K., Phillips N., Kay M.A., Eiermann T., Phan T.T., Volk H.D., Reichenspurner H., Robbins R.C., Schrepfer S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 2011, 20(5):655-667.
25. Stubbendorff M., Deuse T., Hua X., Gossler T., Pahrmann C., Tang-Quan K.R., Reichenspurner H., Robbins R.C., Schrepfe S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells for regenerative therapies. J. Heart Lung Transplant. 2011, 30(Supplement 1):183.
26. Jyothi Prasanna S., Gopalakrishnan Divya, Rani Shankar Shilpa, Vasandan Anoop Babu Pro-inflammatory cytokines, IFNγ and TNFα, influence immune properties of human bone marrow and wharton jelly mesenchymal stem cells differentially. PLoS One 2010, 5(2):9016.
27. Han Kyu Hyun, Ro Han, Hong Ju Ho, Lee Eun Mi, Cho Bumrae, Yeom Hye Jung, Kim Myung-Gyu, Oh Kook-Hwan, Ahn Curie, Yang Jaeseok Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. Transplant Immunol. 2011, 25(1):7-15.
28. Liu Chen-Tao, Yang Yu-Jia, Yin Fei, Wang Xia, Xiao-He Yu, Wang Qing-Hong, Wang Xiao-Li, Xie Min The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation. Cell Immunol. 2006, 244:19-32.
29. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 2003, 31(10):890-896.
30. H. Liu, D.M. Kemeny, B.C. Heng, H.W. Ouyang, A.J. Melendez, T. Cao, The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells, J. Immunol.176 (5) (2006) 2864-2871.
31. Huang X.P., Sun Z., Miyagi Y., McDonald Kinkaid H., Zhang L., Weisel R.D., Li R.K. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010, 122:2419-2429.
32. Yang Q., Peng J., Guo Q.Y., Huang J.X., Zhang L., Yao J., Yang F., Wang S.G., Xu W.J., Wang A.Y., Lu S.B. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Biomaterials 2008, 29:2378-2387.
33. Lu L., Lu S.B., Guo Q.Y., et al. Research of immunoreaction of heterogeneic articular cartilage extracellular matrix derived scaffold. Orthopedic J. China 2010, 01:58-62.
34. Majumdar M.K., Keane-Moore M., Buyaner D., Hardy W.B., Moorman M.A., McIntosh K.R., Mosca J.D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 2003, 10:228-241.
35. Niemeyer P., Kornacker M., Mehlhorn A., Seckinger A., Vohrer J., Schmal H., Kasten P., Eckstein V., Südkamp N.P., Krause U. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng. 2007, 13(1):111-121.
36. Sarugaser R., Lickorish D., Baksh D., Hosseini M.M., Davies J.E. Human Umbilical Cord Perivascular (HUCPV) Cells: A Source of Mesenchymal Progenitors. Stem Cells 2005, 23:220-229.
37. M Crisan, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, L Zhang, C Norotte, PN Teng, J Traas, R Schugar, BM Deasy, S Badylak, HJ Buhring, JP Giacobino, L Lazzari Huard J. and Péault B. A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs. Cell Stem Cell 2008, 3:301-313.
38. Corselli M., Chen C.W., Crisan M., Lazzari L., Péault B. Perivascular ancestors of adult multipotent stem cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1104-1109.
39. Hunt J.S., Langat D.K., McIntire R.H., et al. The role of HLA-G in human pregnancy. Reprod. Biol. Endocrinol. 2006, 4(Suppl 1):S10.
40. Hunt J.S., Petroff M.G., McIntire R.H., et al. HLA-G and immune tolerance in pregnancy. FASEB J. 2005, 19:681-693.
41. Rond S.L., Azéma C., Krawice-Radanne I., et al. Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/Regulatory T Cells. J. Immunol. 2006, 176:3266-3276.
42. Nasef A., Mathieu N., Chapel A., Frick J., François S., Mazurier C., Boutarfa A., Bouchet S., Gorin N.C., Thierry D., Fouillard L. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007, 84(2):231-237.
43. Grohmann U., Fallarino F., Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 2004, 24(5):242-248.
44. P. Han, Z.L. Mi, X.T. Cao, Bone marrow-derived indoleamine-2,3-dioxygenase gene-modified dendritic cells induce transplantation immune tolerance and its mechanism, 2003, doctorial dissertation.
45. Kang J.W., Kang K.S., Koo H.C., et al. Soluble Factors-Mediated Immunomodulatory Effects of Canine Adipose Tissue-Derived Mesenchymal Stem Cells. Stem Cell Dev. 2008, 17:681-694.
46. Harris S.G., Padilla J., Koumas L., et al. Prostaglandins as modulators of immunity. Trends Immunol. 2002, 23(3):144-150.
47. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Stucchi C., Cleris L. Human bone marrow stromal cells suppress T-lympjocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
48. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531-562.
49. Von Boehmer H. Mechanisms of suppression by suppressor Tcells. Nat. Immunol. 2005, 6:338-343.
50. Shi Y., Hu G., Su J., Li W., Chen Q., Shou P., Xu C., Chen X., Huang Y., Zhu Z., Huang X., Han X., Xie N., Ren G. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 2010, 20(5):510-518.
51. Hoogduijn Martin J, Popp Felix, Verbeek Richard, Masoodi Mojgan, Nicolaou Anna, Baan Carla, Dahlke Marc-H The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int. Immunopharmacol. 2010, 10(12):1496-1500.
52. Ghannam Soufiane, Bouffi Carine, Djouad Farida, Jorgensen Christian, Noël Danièle Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res. Ther. 2010, 1:2. 10.1186/scrt2.
53. Chen X., Mcclurg A., Zhou G.Q., Mccaigue M., Armstrong M.A., Li G. Chondrogenic Differentiation Alters the Immunosuppressive Property of Bone Marrow-Derived Mesenchymal Stem Cells, and the Effect Is Partially due to the Upregulated Expression of B7 Molecules. Stem Cells 2007, 25:364-370.